1001pharmacies

1001pharmacies

Online retailer of healthcare products.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor

€0.0

round
investor investor investor investor investor

€0.0

round

N/A

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR201820192020
Revenues000000000000
% growth-(12 %)15 %
EBITDA000000000000
Profit000000000000
% profit margin(90 %)(52 %)(7 %)
EV000000000000
EV / revenue00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x
R&D budget000000000000

Source: Company filings or news article

Notes (0)
More about 1001pharmacies
Made with AI
Edit

1001Pharmacies operated as an online marketplace for health, beauty, and wellness products, connecting consumers with a network of physical pharmacies across France. The company was founded in 2012 by Cédric O'Neill, a pharmacist with a Master's in Entrepreneurship, and Sabine Safi, who was completing her studies in management and e-business. The idea originated with O'Neill and was developed after the two met at a Startup Weekend in Toulouse; their complementary skills formed the foundation of the venture. Their goal was to establish a leading position in the online pharmacy market by collaborating directly with brick-and-mortar establishments.

The platform launched in late 2012, initially partnering with about a dozen pharmacies to sell parapharmacy items. The business model was twofold: it charged partner pharmacies a service fee, reported as a 10-12% commission on sales, and also generated revenue by selling advertising space to laboratories wanting to reach its customer base. This structure provided independent pharmacies with a ready-made technical solution and the marketing power of a unified platform, which they could not achieve alone. The company's primary target demographic was women aged 25-40. The platform offered a wide catalog of products, including cosmetics, medical equipment, veterinary supplies, and organic products, which was a key factor in its growth. By providing products sourced directly from identified French pharmacists, the company aimed to offer a reliable alternative to other online vendors and combat the issue of counterfeit products.

1001Pharmacies demonstrated rapid growth, with sales increasing from approximately €1 million in 2013 to a projected €22 million by the end of 2015. This expansion was fueled by several funding rounds, including an initial €100K and a subsequent €8 million raised from investors like Newfund, CM-CIC Capital Privé, and notable business angels such as Olivier Mathiot (PriceMinister) and Xavier Niel (via Kima Ventures). Over the years, the leadership structure evolved significantly. Sabine Safi departed in July 2016 due to diverging views on management style with O'Neill. Cédric O'Neill also left the company, with Julien Mazerolle taking over as president in April 2017. In February 2019, 1001Pharmacies' parent company, Enova Santé, was acquired by the Belgian group Pharmasimple in a deal valued at €8 million. Keywords: online pharmacy, parapharmacy, e-commerce marketplace, health products, beauty products, wellness products, Cédric O'Neill, Sabine Safi, French marketplace, cosmetics, veterinary supplies, medical equipment, pharmaceutical sales, digital health, Enova Santé, Pharmasimple, Olivier Mathiot, Kima Ventures, online retail

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo